Management of Preterm Labor: Atosiban or Nifedipine?

Overview

Journal Int J Womens Health

Publisher Dove Medical Press

Specialty Gynecology & Obstetrics

Date 2010 Nov 13

PMID 21072306

Citations 8

Authors

Roel De Heus

Eduard J H Mulder

Gerard H A Visser

Affiliations

Soon will be listed here.

Abstract

Preterm birth is strongly associated with neonatal death and long-term neurological morbidity. The purpose of tocolytic drug administration is to postpone threatening preterm delivery for 48 hours to allow maximal effect of antenatal corticosteroids and maternal transportation to a center with specialized neonatal care facilities. There is uncertainty about the value of atosiban (oxytocin receptor antagonist) and nifedipine (calcium channel blocker) as first-line tocolytic drugs in the management of preterm labor. For nifedipine, concerns have been raised about unproven safety, lack of placebo-controlled trials, and its off-label use. The tocolytic efficacy of atosiban has also been questioned because of a lack of reduction in neonatal morbidity. This review discusses the available evidence, the pros and cons of either drug and aims to provide information to support a balanced choice of first-line tocolytic drug: atosiban or nifedipine?

Citing Articles

Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy.

Siricilla S, Hansen C, Rogers J, De D, Simpson C, Waterson A Pharmacol Res. 2023; 195:106876.

PMID: 37536638 PMC: 10712649. DOI: 10.1016/j.phrs.2023.106876.

Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience.

Al-Riyami N, Al-Badri H, Jaju S, Pillai S Sultan Qaboos Univ Med J. 2021; 21(2):e260-e265.

PMID: 34221474 PMC: 8219335. DOI: 10.18295/squmj.2021.21.02.015.

Landscape of Preterm Birth Therapeutics and a Path Forward.

Coler B, Shynlova O, Boros-Rausch A, Lye S, McCartney S, Leimert K J Clin Med. 2021; 10(13).

PMID: 34209869 PMC: 8268657. DOI: 10.3390/jcm10132912.

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.

Ahmad J, Ikram S, Ahmad F, Rehman I, Mushtaq M Heliyon. 2020; 6(7):e04502.

PMID: 32754651 PMC: 7377705. DOI: 10.1016/j.heliyon.2020.e04502.

A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production.

Patel S, Volpe A, Awwad S, Schatzlein A, Haider S, Liu B Sci Rep. 2020; 10(1):7269.

PMID: 32350300 PMC: 7190706. DOI: 10.1038/s41598-020-64070-9.

References

Lindow S, Davies N, Davey D, Smith J . The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol. 1988; 95(12):1276-81. DOI: 10.1111/j.1471-0528.1988.tb06818.x. View

Al-Omari W, Al-Shammaa H, Al-Tikriti E, Ahmed K . Atosiban and nifedipine in acute tocolysis: a comparative study. Eur J Obstet Gynecol Reprod Biol. 2006; 128(1-2):129-34. DOI: 10.1016/j.ejogrb.2005.12.010. View

Hodges R, Barkehall-Thomas A, Tippett C . Maternal hypoxia associated with nifedipine for threatened preterm labour. BJOG. 2004; 111(4):380-1. DOI: 10.1111/j.1471-0528.2004.00092.x. View

Nassar A, Ghazeeri G, Usta I . Nifedipine-associated pulmonary complications in pregnancy. Int J Gynaecol Obstet. 2007; 97(2):148-9. DOI: 10.1016/j.ijgo.2007.01.011. View

Parasuraman R, Gandhi M, Liversedge N . Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion. BJOG. 2006; 113(7):844-5. DOI: 10.1111/j.1471-0528.2006.00964.x. View

King J, Flenady V, Papatsonis D, Dekker G, Carbonne B . Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 2002; (2):CD002255. DOI: 10.1002/14651858.CD002255. View

Kashanian M, Akbarian A, Soltanzadeh M . Atosiban and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet. 2005; 91(1):10-4. DOI: 10.1016/j.ijgo.2005.06.005. View

Oei S . Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events. Eur J Obstet Gynecol Reprod Biol. 2006; 126(2):137-45. DOI: 10.1016/j.ejogrb.2006.03.001. View

Ferguson 2nd J, Dyson D, Holbrook Jr R, Schutz T, Stevenson D . Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol. 1989; 161(3):788-95. DOI: 10.1016/0002-9378(89)90403-1. View

10.

Coomarasamy A, Knox E, Gee H, Song F, Khan K . Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. BJOG. 2003; 110(12):1045-9. View

11.

Pirhonen J, Erkkola R, Ekblad U, Nyman L . Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms. Obstet Gynecol. 1990; 76(5 Pt 1):807-11. DOI: 10.1097/00006250-199011000-00016. View

12.

Verhaert D, Van Acker R . Acute myocardial infarction during pregnancy. Acta Cardiol. 2004; 59(3):331-9. DOI: 10.2143/AC.59.3.2005191. View

13.

Oei S, Mol B, De Kleine M, Brolmann H . Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet Gynecol Scand. 1999; 78(9):783-8. View

14.

Major C, Lewis D, Harding J, Porto M, Garite T . Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol. 1994; 170(1 Pt 1):102-6. DOI: 10.1016/s0002-9378(94)70392-2. View

15.

. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG. 2001; 108(2):133-42. View

16.

Guclu S, Saygili U, Dogan E, Demir N, Baschat A . The short-term effect of nifedipine tocolysis on placental, fetal cerebral and atrioventricular Doppler waveforms. Ultrasound Obstet Gynecol. 2004; 24(7):761-5. DOI: 10.1002/uog.1770. View

17.

Papatsonis D, van Geijn H, Ader H, Lange F, Bleker O, Dekker G . Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 1997; 90(2):230-4. DOI: 10.1016/S0029-7844(97)00182-8. View

18.

Norton M, Merrill J, Cooper B, Kuller J, Clyman R . Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993; 329(22):1602-7. DOI: 10.1056/NEJM199311253292202. View

19.

Van Geijn H, Lenglet J, Bolte A . Nifedipine trials: effectiveness and safety aspects. BJOG. 2005; 112 Suppl 1:79-83. DOI: 10.1111/j.1471-0528.2005.00591.x. View

20.

King J, Flenady V, Cole S, Thornton S . Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005; (2):CD001992. DOI: 10.1002/14651858.CD001992.pub2. View